Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02494726 · ClinicalTrials.gov registry record
Prospective Analysis of the Use of TEG in Stroke Patients
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 178
- Enrollment target
NCT02494726 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 178 participants.
The verdict
NCT02494726 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 178 participants
- Enrollment target
Study Summary
The overall purpose of this study is to evaluate how effective Thromboelastography (TEG) is on identifying ischemic and hemorrhagic stroke patients at increased risk for bleeding after receiving tissue plasminogen activator (tPA), as well as on differentiating between patients in whom optimal thrombolysis has been achieved, and those whom it has not.
Interventions
- OTHER Thromboelastography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2009-11 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02494726
The ClinicalTrials.gov registry entry for NCT02494726 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Thromboelastography is the first listed.
NCT02494726 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02494726 about?
NCT02494726 is a clinical study titled "Prospective Analysis of the Use of TEG in Stroke Patients". The overall purpose of this study is to evaluate how effective Thromboelastography (TEG) is on identifying ischemic and hemorrhagic stroke patients at increased risk for bleeding after receiving tissue plasminogen activator (tPA), as well as on differentiating between patients in whom optimal thromb...
What is the current status of trial NCT02494726?
This trial is currently completed. The enrollment target is 178 participants. The study started on 2009-11. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02494726?
The interventions under investigation include: Thromboelastography (OTHER).
Who is sponsoring clinical trial NCT02494726?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.